[OPNT] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[OPNT] Opiant Pharmaceuticals, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 34.29%
YoY- 83.70%
Quarter Report
OPNT's Result
OPNT's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 31/10/15 CAGR
Revenue 14,041 8,601 20,494 4,248 22 1,121 120 123.52%
PBT 3,417 725 10,684 -918 -5,633 -601 -11,110 -
Tax 548 -6 -24 -20 -34 -19 2 158.07%
NP 3,417 725 10,684 -918 -5,633 -601 -11,110 -
Tax Rate -16.03% 0.85% 0.22% - - - - -
Total Cost 10,624 7,876 9,810 5,166 5,655 1,722 11,230 -0.93%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 31/10/15 CAGR
NP Margin 24.34 8.43 52.13 -21.61 -25,604.55 -53.57 -9,258.35 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 31/10/17 31/10/16 31/10/15 CAGR
EPS 0.77 0.17 2.64 -0.32 -2.77 -0.30 -6.00 -
EPS Diluted 0.56 0.15 1.97 -0.32 -2.77 -0.30 -6.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.